Clinical Trials Directory

Trials / Completed

CompletedNCT06448533

The Predictive Value of Prostate Spherical Volume Ratio in Lower Urinary Tract Symptoms and Clinical Progression of Benign Prostatic Hyperplasia:A Single-center Paired Validating Confirmatory Study

Status
Completed
Phase
Study type
Observational
Enrollment
153 (actual)
Sponsor
Shanghai East Hospital · Academic / Other
Sex
Male
Age
40 Years
Healthy volunteers
Not accepted

Summary

This study was a retrospective cohort study clinical trial designed to assess the predictive ability of the prostate morphometric parameter, Prostate Spherical Volume Ratio, in the lower urinary tract symptoms and clinical progression of benign prostatic hyperplasia; and to compare the predictive ability of other anatomical parameters of the prostate (prostatic urethral length, intravesical prostatic protrusion, presumed circle area ratio, and prostate volume) in the lower urinary tract symptoms and clinical progression of benign prostatic hyperplasia

Detailed description

This was a retrospective observational study approved by the Ethics Committee of Shanghai Oriental Hospital. We collected patients with BPH who underwent MRI, urine flow measurement and completed the IPSS questionnaire in our hospital between September 2022 and April 2023, measured each anatomical parameter of the patient's prostate by MRI, analysed the relationship of these prostate parameters with IPSS and urine flow, and conducted a follow-up of the clinical progression of the prostate in these patients to evaluate the predictive efficacy of prostate parameters for LUTS and clinical progression of benign prostatic hyperplasia.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2022-09-10
Primary completion
2023-03-30
Completion
2024-03-30
First posted
2024-06-07
Last updated
2024-06-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06448533. Inclusion in this directory is not an endorsement.